- Rating
- 2
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 3
Read review
Paper summary
This paper studies drug–disease association (DDA) prediction, addressing the limitations of existing multi-view methods that primarily align attribute and relational representations without explicitly leveraging their complementary information. To address this problem, proposing CARE, a cross-view masked graph learning framework that employs reciprocal reconstruction between attribute and relation views, type-aware contrastive alignment, and task-conditioned multi-task learning with drug–protein (DPI) and disease–protein (DPA) associations. Experiments on three benchmark datasets using 10-fold cross-validation demonstrate that CARE consistently outperforms 12 baseline methods across six evaluation metrics. Ablation studies further show the contributions of reciprocal reconstruction, contrastive alignment, and auxiliary relation supervision, while case studies provide supporting clinical and literature evidence for top-ranked drug candidates.
Critical strengths
The paper clearly explained the methodological strengths of this study through both experiments and logical reasoning. The necessary experiments are also well demonstrated using benchmark datasets.
Critical weaknesses
The performance scores on these benchmarks are already close to 100%, raising concerns that the models may be competing on already saturated benchmarks. While demonstrating the effectiveness of the proposed method using benchmark datasets is reasonable, additional comparisons on more recent external benchmarks or newly constructed experimental settings seem necessary.
Questions for authors
- In general, the number of proteins is much larger than that of drugs and diseases. Even in datasets such as MSI and Hetionet, dense PPI information can make it difficult to identify meaningful drug–protein–disease relationships. Although the proposed method achieves nearly perfect scores on the current benchmark datasets, it is unclear whether similar performance can be achieved on external datasets or larger KGs with highly imbalanced degree distributions. The slight performance improvements on the benchmarks are acknowledged, but whether the proposed methodology remains effective on more complex, heterogeneous biomedical KGs is still questionable.
- Is there a case study showing how the two views actually complement each other's missing information? Typically, cross-attention or embedding fusion can enhance shared information, while this study emphasizes that the two views can recover complementary information from each other. An embedding-level case study demonstrating this mutual recovery would better support the main claim.
- The code could not be found in the supplementary materials. Providing the code would be helpful for reproducibility. And main architecture figure seems to illustrate the framework somewhat differently from the methodological description. A clearer illustration would help readers better understand the proposed approach.